FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When ...

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

The current strategy for managing chronic gout is the use of uric-acid-lowering drugs to reduce urate production or of a uricosuric agent to promote renal uric acid excretion. Probenecid is ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Radiographic scoring of articular damage is useful for evaluating disease progression and response to treatment in patients with rheumatic diseases; currently, however, there is no validated ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

Uric acid crystals can accumulate under the skin and form lumps called "tophi." Chronic (long-term) gout can cause knee ...

Marathon runner Niven Hopkins was diagnosed with stage four chronic kidney disease, discovering that his ‘sore toe’ was ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

The third phase, inter-critical gout, is a period between acute attacks when the patient is symptom-free. Finally, chronic ...

Dr Hilary Jones has said that the prevalence of gout is set to increase up to 70 per cent in the coming years - and ...